Patrick Wood
Stock Analyst at Morgan Stanley
(3.16)
# 1,158
Out of 5,131 analysts
118
Total ratings
51.11%
Success rate
2.04%
Average return
Main Sectors:
Stocks Rated by Patrick Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintains: Equal-Weight | $76 → $83 | $83.45 | -0.54% | 7 | Dec 8, 2025 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $123 → $135 | $137.07 | -1.51% | 3 | Dec 2, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Equal-Weight | $17 → $23 | $21.70 | +5.99% | 6 | Dec 2, 2025 | |
| RXST RxSight | Maintains: Equal-Weight | $9 → $10 | $8.84 | +13.12% | 3 | Dec 2, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $56 → $51 | $32.83 | +55.35% | 4 | Dec 2, 2025 | |
| DXCM DexCom | Upgrades: Overweight | $63 → $75 | $67.40 | +11.28% | 10 | Dec 2, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Overweight | $197 → $210 | $202.75 | +3.58% | 6 | Dec 2, 2025 | |
| BAX Baxter International | Maintains: Underweight | $19 → $15 | $21.07 | -28.81% | 6 | Dec 2, 2025 | |
| BLCO Bausch + Lomb | Upgrades: Overweight | $14 → $21 | $17.21 | +22.02% | 9 | Dec 2, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Equal-Weight | $74 → $80 | $87.28 | -8.34% | 8 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $125 → $130 | $97.64 | +33.14% | 7 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $84 → $80 | $80.13 | -0.16% | 5 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $276 → $295 | $256.82 | +14.87% | 7 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $75 → $81 | $85.13 | -4.85% | 9 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $80 → $103 | $86.14 | +19.57% | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $110 → $72 | $112.92 | -36.24% | 4 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $191 → $173 | $112.81 | +53.36% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $234 → $317 | $289.04 | +9.67% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $10 | $2.61 | +283.14% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $50 → $37 | $22.12 | +67.27% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $111.45 | - | 5 | Dec 11, 2017 |
The Cooper Companies
Dec 8, 2025
Maintains: Equal-Weight
Price Target: $76 → $83
Current: $83.45
Upside: -0.54%
TransMedics Group
Dec 2, 2025
Maintains: Equal-Weight
Price Target: $123 → $135
Current: $137.07
Upside: -1.51%
Tandem Diabetes Care
Dec 2, 2025
Maintains: Equal-Weight
Price Target: $17 → $23
Current: $21.70
Upside: +5.99%
RxSight
Dec 2, 2025
Maintains: Equal-Weight
Price Target: $9 → $10
Current: $8.84
Upside: +13.12%
PROCEPT BioRobotics
Dec 2, 2025
Maintains: Overweight
Price Target: $56 → $51
Current: $32.83
Upside: +55.35%
DexCom
Dec 2, 2025
Upgrades: Overweight
Price Target: $63 → $75
Current: $67.40
Upside: +11.28%
Becton, Dickinson and Company
Dec 2, 2025
Maintains: Overweight
Price Target: $197 → $210
Current: $202.75
Upside: +3.58%
Baxter International
Dec 2, 2025
Maintains: Underweight
Price Target: $19 → $15
Current: $21.07
Upside: -28.81%
Bausch + Lomb
Dec 2, 2025
Upgrades: Overweight
Price Target: $14 → $21
Current: $17.21
Upside: +22.02%
GE HealthCare Technologies
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $74 → $80
Current: $87.28
Upside: -8.34%
Oct 23, 2025
Maintains: Overweight
Price Target: $125 → $130
Current: $97.64
Upside: +33.14%
Aug 21, 2025
Maintains: Equal-Weight
Price Target: $84 → $80
Current: $80.13
Upside: -0.16%
Aug 8, 2025
Maintains: Overweight
Price Target: $276 → $295
Current: $256.82
Upside: +14.87%
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $75 → $81
Current: $85.13
Upside: -4.85%
Jul 15, 2025
Upgrades: Overweight
Price Target: $80 → $103
Current: $86.14
Upside: +19.57%
May 6, 2025
Maintains: Underweight
Price Target: $110 → $72
Current: $112.92
Upside: -36.24%
May 5, 2025
Maintains: Overweight
Price Target: $191 → $173
Current: $112.81
Upside: +53.36%
Nov 11, 2024
Maintains: Overweight
Price Target: $234 → $317
Current: $289.04
Upside: +9.67%
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $18 → $10
Current: $2.61
Upside: +283.14%
Jul 15, 2024
Downgrades: Underweight
Price Target: $50 → $37
Current: $22.12
Upside: +67.27%
Dec 11, 2017
Upgrades: Buy
Price Target: n/a
Current: $111.45
Upside: -